See how top analysts and institutions rate ASTS — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Barclays | Downgrade | Overweight → Underweight | $60 | 2025-10-17 |
| Scotiabank | Downgrade | Sector Perform → Sector Underperform | 2025-10-07 | |
| UBS | Downgrade | Buy → Neutral | $43 | 2025-09-09 |
| William Blair | Initiated | Mkt Perform | 2025-08-21 | |
| BofA Securities | Initiated | Neutral | $55 | 2025-06-25 |
| Scotiabank | Downgrade | Sector Outperform → Sector Perform | $45.40 | 2025-06-23 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 0 | 4 | 4 | 0 | 2 |
| October 2025 | 1 | 4 | 5 | 0 | 0 |
| September 2025 | 1 | 5 | 4 | 0 | 0 |
| July 2025 | 1 | 4 | 3 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for ASTS, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
